AR123902A2 - Composición veterinaria oral para el control de inapetencia para un gato o un perro - Google Patents
Composición veterinaria oral para el control de inapetencia para un gato o un perroInfo
- Publication number
- AR123902A2 AR123902A2 ARP210102942A ARP210102942A AR123902A2 AR 123902 A2 AR123902 A2 AR 123902A2 AR P210102942 A ARP210102942 A AR P210102942A AR P210102942 A ARP210102942 A AR P210102942A AR 123902 A2 AR123902 A2 AR 123902A2
- Authority
- AR
- Argentina
- Prior art keywords
- capromorelin
- composition
- appetite
- livestock
- syringe
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención da a conocer un método para tratar la pérdida de peso inducida por inapetencia en uno o más animales de compañía o ganado. El método consiste en administrar una cantidad terapéuticamente efectiva de una composición con contenido de capromorelina al animal de compañía o ganado. Opcionalmente, se puede agregar uno o más agentes saborizantes o agentes enmascaradores del sabor a la composición con contenido de capromorelina para realzar o enmascarar el sabor de la composición para el animal de compañía o ganado. Reivindicación 1: Un método para tratar la inapetencia en un animal de compañía, que comprende el paso de administrar al animal de compañía una cantidad terapéuticamente efectiva de una composición con contenido de capromorelina. Reivindicación 30: Un método para aumentar la masa muscular magra y tratar la inapetencia en un animal no humano que comprende la administración de una dosis terapéuticamente efectiva de una composición de capromorelina al animal no humano. Reivindicación 111: Un kit para usar en el tratamiento de la inapetencia en animales no humanos, kit que comprende: una jeringa; un recipiente que contiene una formulación farmacéutica, formulación farmacéutica que comprende una composición con contenido de capromorelina e indicaciones para instruir a un usuario para retirar aproximadamente una dosis de la formulación farmacéutica del recipiente empleando la jeringa y administrar la composición farmacéutica al animal no humano utilizando la jeringa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706164P | 2012-09-27 | 2012-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR123902A2 true AR123902A2 (es) | 2023-01-25 |
Family
ID=50339468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103486A AR092713A1 (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto para el control de la inapetencia |
| ARP210102942A AR123902A2 (es) | 2012-09-27 | 2021-10-22 | Composición veterinaria oral para el control de inapetencia para un gato o un perro |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103486A AR092713A1 (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto para el control de la inapetencia |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11090292B2 (es) |
| EP (3) | EP3524260B1 (es) |
| JP (2) | JP6779618B2 (es) |
| KR (6) | KR20210009438A (es) |
| CN (2) | CN111419845A (es) |
| AR (2) | AR092713A1 (es) |
| AU (2) | AU2013323349B2 (es) |
| BR (1) | BR112015006282B1 (es) |
| CA (1) | CA2886091C (es) |
| DK (1) | DK3524260T3 (es) |
| ES (1) | ES2959427T3 (es) |
| MX (2) | MX2015003564A (es) |
| NZ (2) | NZ707174A (es) |
| PL (1) | PL3524260T3 (es) |
| PT (1) | PT3524260T (es) |
| RU (1) | RU2648958C2 (es) |
| TW (3) | TW202106298A (es) |
| WO (1) | WO2014052780A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012141061A (ru) | 2010-02-26 | 2014-04-10 | Раквалиа Фарма Инк. | Агонист рецептора грелина для лечения кахексии |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| CN111419845A (zh) | 2012-09-27 | 2020-07-17 | 阿莱塔纳治疗学股份有限公司 | 应用控制食欲不振的化合物的组合物和方法 |
| US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| US9700591B2 (en) * | 2015-01-28 | 2017-07-11 | Aratana Therapeutics, Inc. | Compositions and methods for chronic use of a weight-gaining compound |
| US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| EP3525597A1 (en) * | 2016-11-11 | 2019-08-21 | Hill's Pet Nutrition, Inc. | Compositions and methods of pet food |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US193273A (en) * | 1877-07-17 | Improvement in material for pulley-covers | ||
| JP2893901B2 (ja) * | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| CA2095786A1 (en) * | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
| EP1181933A3 (en) * | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) * | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| JP2007532495A (ja) * | 2004-04-07 | 2007-11-15 | ガストロテック・ファルマ・アクティーゼルスカブ | グレリン欠乏を治療するための分泌促進薬の使用 |
| WO2006045313A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
| US8226973B2 (en) * | 2005-11-02 | 2012-07-24 | Nestec, S. A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| US7981860B2 (en) * | 2006-03-13 | 2011-07-19 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
| WO2008039415A2 (en) * | 2006-09-27 | 2008-04-03 | Ipsen Pharma S.A.S. | Analogs of ghrelin substituted at the n-terminal |
| JP2008127377A (ja) * | 2006-11-24 | 2008-06-05 | Jichi Medical Univ | Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。 |
| US20080226802A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Beverage having natural sweeteners with one or more stevia components and source of berry |
| TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) * | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) * | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| JP5258783B2 (ja) * | 2007-11-12 | 2013-08-07 | 三栄源エフ・エフ・アイ株式会社 | ステビア抽出物の甘味質改善 |
| US8895588B2 (en) * | 2009-03-26 | 2014-11-25 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| RU2012141061A (ru) * | 2010-02-26 | 2014-04-10 | Раквалиа Фарма Инк. | Агонист рецептора грелина для лечения кахексии |
| CN111419845A (zh) | 2012-09-27 | 2020-07-17 | 阿莱塔纳治疗学股份有限公司 | 应用控制食欲不振的化合物的组合物和方法 |
-
2013
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Ceased
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko not_active Ceased
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 KR KR1020257009208A patent/KR20250048114A/ko active Pending
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Ceased
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active Ceased
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en not_active Ceased
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active Ceased
- 2013-09-27 EP EP23191187.6A patent/EP4302825A3/en active Pending
-
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
-
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
-
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
-
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092713A1 (es) | Composiciones y metodos de uso de un compuesto para el control de la inapetencia | |
| EP2460403A4 (en) | STEATOHEPATITIS LIVER CANCER MODEL IN ANIMAL | |
| BR112013020802A2 (pt) | métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais | |
| BR112012010689B8 (pt) | mistura antifúngica com organismo fúngico | |
| BR112012015961A2 (pt) | composições incluindo piruvato para animais de estimação e métodos de uso dos mesmos | |
| BR112013018839A2 (pt) | métodos e composições para o tratamento, a redução ou a prevenção de deterioração do sistema visual dos animais | |
| BRPI0923783A8 (pt) | Métodos para induzir perda de gordura corporal, e para aumentar a percentagem de massa de músculo magro em um animal de estimação | |
| RU2014148977A (ru) | Обработка популяции рыб луфенуроном | |
| AR103555A1 (es) | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso | |
| MX2019002386A (es) | Uso de oligosacaridos de leche humana en el engorde de terneros. | |
| MX2021011550A (es) | Formulaciones de pregabalina y uso de las mismas. | |
| AR091769A1 (es) | Formulaciones orales de dosis unica y metodos para el tratamiento de gatos con el ectoparasiticida espinosad | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| MX2014014934A (es) | Metodo para prevenir la dermatitis por alergia a las pulgas en animales de compañía. | |
| RU2009108805A (ru) | Способ коррекции гиперфибриногенемии при анемии у новорожденных телят и поросят | |
| Andrushko et al. | Efficacy of Toltarox at Eimeria infection of cattle youngsters. | |
| EA201391001A1 (ru) | Способы контролирования боли у животных семейства лошадиных с применением трансдермального раствора фентанила | |
| Aguayo-Ulloa et al. | Effect of full enrichment on behaviour and welfare of lambs | |
| EA201500014A1 (ru) | Средство для лечения кокцидиозов у птиц и животных | |
| MD80Y (en) | Method of prophylaxis and treatment of parasitoses to cattle | |
| UA98880U (uk) | Спосіб стимуляції росту поросят-сисунів | |
| RU2015154195A (ru) | Способ лечения зубного камня, гингивитов и парадонтитов мелких домашних животных | |
| MHOW | Full Length Case Study | |
| UA93930U (uk) | Спосіб лікування дерматофітозів собак | |
| GB2482526A (en) | Praziquantel suspendable powder as an immersion fish treatment for parasites |